Author:
Hewison Cathy,Ferlazzo Gabriella,Avaliani Zaza,Hayrapetyan Armen,Jonckheere Sylvie,Khaidarkhanova Zarema,Mohr Erika,Sinha Animesh,Skrahina Alena,Vambe Debrah,Vasilyeva Irina,Lachenal Nathalie,Varaine Francis
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference9 articles.
1. World Health Organization. Global Tuberculosis Report 2016 [cited 2017 Jul 20]. http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf
2. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.;Ahuja;PLoS Med,2012
3. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.;Falzon;Eur Respir J,2013
4. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR TB cohort study.;Bonnet;Int J Tuberc Lung Dis,2016
5. European Medicines Agency. Deltyba (delamanid) [cited 2017 Jan 6]. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002552/human_med_001699.jsp&mid=WC0b01ac058001d124
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献